Market update: Following the announcement of MCO extension in several states, the local bourse endured a rough ride as economic recovery progress took another backseat. The weakness was also largely in line with the negative performance across regional peers which we reckon that the pullback is deem to be healthy to allow the recent gains to be digested. While the market liquidity has yet to taper, we think the rotational play amongst the lower liners may prolong with the on-going batch of corporate earnings release largely in focus.
Sector focus: In view of the recent downturn in gloves manufacturer stocks, we think that valuations have now turned more appealing. Vaccine-related stocks are also in the limelight amid the roll-out of national vaccination plan. CPO price re-capturing RM3,600/MT may garner some trading interests within the plantation sector, while energy stocks may continue to ride on the higher crude oil prices.
https://www.linkedin.com/posts/jaypadasian_cansino-biologics-steps-into-the-spotlight-activity-6768054039906279425-GMae Interim analyses have shown that CanSino’s vaccine is well tolerated across age groups, with no reports of serious adverse events. Outside of the trials, more than 150,000 members of the Chinese military have already received the vaccine under an emergency use agreement. Experts have touted the desirability of a single-dose vaccine at a time when manufacturing capacity is scarce and infection rates are soaring. In addition to short-term efficacy data, CanSino’s results will ultimately provide the first measures of the durability of the protection conferred by a COVID-19 vaccine. The trial, which spans 70 sites and 40,000 participants in Argentina, Chile, Mexico, Pakistan, and Russia, includes a cohort of participants who are being tracked for a full year following vaccination. To date, CanSino is the only vaccine developer with a trial spanning that length of time. Those results are expected in the Fall. CanSino is also testing a two-dose regimen in China, a trial that is likely to be among the first in the world to provide safety and efficacy data on a COVID-19 vaccine in young children. The two-dose trial, which began in September, includes participants as young as six years old.
Khairy said will order J J vaksin already. Qty unknown yet. Wait for the confirmation later. So Msia will have 6 vaksin suppliers now. Not include the other china vaksin in 3rd phase trial started in Msia one. More competition now. Correct?
Spore Moderna Vaksin arrived earlier today instead of in March. Will Msia follow to get Moderna vaksin also. Who know lah. Msia Pfizer vaksin will arrive in next few days. Solution Vaksin still havent get necessary approval yet kah. Correct?
latest news Sinovac vaksin arrive on 27/2. pfizer vaksin arrive this Sunday. Cansino bila mau sampai Solution plant. Solution plant ready already kah. Promoters ada news terkini to share or not? Sharing is Caring. Katak takda sharing vaksin only jadi kaki pukul kah. Sharimg only TP rm2.00. This one call sharing also kah. Correct?
Posted by lee9fold > Dec 9, 2020 8:32 PM | Report Abuse
piercing candle stick pattern, this is rare piercing pattern where it almost cover the whole previous red candle, it shows super strong reversal, hopefully a genuine 1 and will continue uptrend
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
Report Abuse
Please Sign In to report this post as abuse.
Market Buzz
No result.
Featured Posts
MQ Trader
Introducing MY's First IPO Fund for Sophisticated Investors!
MQ Chat
New Update. Discover investment communities that resonate with your ideas
MQ Trader
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
0:17
New IPO: Supreme Consolidated Resources Berhad, a distributor and warehouser of F&B products, aims to list on the ACE Market!
MQ Trader 375 views | 10 d ago
0:17
New IPO: O&G healthcare service provider, Metro Healthcare Berhad aims to list on the Ace Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
DreamKeeper
1,243 posts
Posted by DreamKeeper > 2021-02-17 21:25 | Report Abuse
Sudah okay juga tuhhh